8-K: Helio Secures $250K Debt Financing with Convertible Note

Sentiment:

Debt and Equity Financing


Helio Corporation has entered into a Securities Purchase Agreement to issue a $275,000 promissory note and 25,000 common shares to an accredited investor, raising approximately $200,000 net proceeds for working capital.

Capital raiseHelio Corporation entered into a Securities Purchase Agreement to issue a promissory note with a principal amount of $275,000 for a purchase price of $250,000.The company also issued 25,000 unregistered shares of its common stock as additional consideration.Net proceeds from this capital raise were approximately $200,000 after deducting legal and placement agent fees.The company has retained Network 1 Financial Securities to assist in connection with potential future debt and equity capital raises.
Worse than expectedThe effective cost of capital is high, with a $25,000 original issue discount on a $250,000 investment and an additional 25,000 common shares issued, plus a 10% annual interest rate.Net proceeds to the company are only $200,000 from a $275,000 principal note, indicating a significant portion of the financing is consumed by fees and discounts.The conversion terms are highly dilutive, tied to 90% of the lowest closing price over 10 trading days, which can lead to substantial shareholder value erosion if the stock price is volatile or declines.The penalty for default is severe, requiring repayment at 150% of the outstanding principal plus interest.

Summary

  • Helio Corporation issued a promissory note with a principal amount of $275,000 for a purchase price of $250,000, reflecting a $25,000 original issue discount.
  • The note bears interest at 10% per annum and matures 12 months from the issue date (August 26, 2026).
  • Additionally, 25,000 unregistered shares of common stock were issued to the investor as additional consideration.
  • Net proceeds from the transaction were approximately $200,000 after deducting legal and placement agent fees.
  • Proceeds are intended for general corporate and working capital purposes.
  • The note is convertible into common stock at 90% of the lowest closing price during the 10 trading days prior to conversion, upon certain events of default or missed payments.
  • Monthly amortization payments begin on February 26, 2026.
  • The company has retained Network 1 Financial Securities as a placement agent and for financial advisory services.

Sentiment

Score: 3

Explanation: The financing provides needed capital but comes with very unfavorable and potentially highly dilutive terms, including a significant original issue discount, high interest rate, and aggressive conversion features. The high cost of capital and strong investor protections suggest the company is in a challenging financial position.

Positives

  • Secured $200,000 in net proceeds for general corporate and working capital purposes, improving liquidity.
  • The company may prepay the note without penalty, offering flexibility.

Negatives

  • The company received $250,000 for a $275,000 principal note, representing a $25,000 original issue discount.
  • Net proceeds were further reduced to approximately $200,000 after legal and placement agent fees, indicating a high cost of capital.
  • The note bears a high interest rate of 10% per annum, increasing debt servicing costs.
  • Conversion terms are highly dilutive, allowing conversion at 90% of the lowest closing price during the 10 trading days prior to conversion, which can significantly increase the number of shares issued.
  • Upon an event of default, the note becomes immediately due and payable at 150% of the outstanding principal plus accrued interest, imposing a substantial penalty.
  • The company issued 25,000 unregistered common shares as additional consideration, further contributing to dilution.
  • The "Most Favored Nation" provision means the company must offer the investor any more favorable terms granted in future financings, potentially limiting future financing flexibility.
  • The holder can require repayment of up to 25% of proceeds from future equity lines or Regulation A offerings, or 100% from asset sales/M&A, or 25% from other equity/debt/warrant exercises (after 180 days), which could constrain future capital allocation.

Risks

  • Significant Dilution Risk: The conversion terms (90% of the lowest closing price over 10 trading days) and the issuance of 25,000 commitment shares pose a substantial risk of dilution to existing shareholders.
  • High Cost of Capital: The original issue discount, 10% interest rate, and placement agent fees indicate a high cost of capital, which could strain financial resources.
  • Default Penalties: Events of default trigger immediate repayment at 150% of the outstanding principal plus interest, which could lead to severe financial distress or further dilutive conversions.
  • Future Financing Constraints: The "Most Favored Nation" clause and the holder's right to demand repayment from future capital raises or asset sales could limit the company's flexibility in securing future financing or deploying capital.
  • SEC Reporting Compliance: Failure to remain current in SEC reporting obligations is an event of default, carrying significant consequences.
  • Liquidity Risk: The company's ability to meet monthly amortization payments starting February 26, 2026, and the final maturity payment on August 26, 2026, is crucial.
  • Market Price Volatility: The conversion price being tied to the lowest closing price over 10 trading days means that a declining stock price could lead to more shares being issued upon conversion, exacerbating dilution.

Future Outlook

The company intends to use the net proceeds of approximately $200,000 for general corporate and working capital purposes, indicating a focus on maintaining current operations and supporting business development.

Industry Context

This type of financing, characterized by a high original issue discount, a substantial interest rate, and dilutive conversion features, is often indicative of a smaller company or one with limited access to more traditional, less costly capital markets. The engagement of a placement agent like Network 1 Financial Securities further suggests the company is actively seeking to navigate complex capital market structures to secure necessary funding, a common trend for micro-cap or early-stage public companies. The 'Most Favored Nation' clause and the ability of the investor to demand repayment from future capital raises are terms typically seen in financings where the investor seeks strong protections and preferential treatment, reflecting a higher perceived risk.

Comparison to Industry Standards

  • The 10% annual interest rate and $25,000 original issue discount on a $250,000 investment are significantly higher than typical corporate debt for established companies, which might see rates in the 3-7% range for investment-grade debt. For example, a company like Apple or Microsoft would secure debt at much lower rates (e.g., 1-3%).
  • The conversion feature, allowing conversion at 90% of the lowest closing price over 10 trading days, is highly dilutive and more aggressive than standard convertible notes, which often use a fixed conversion price or a smaller discount to the market price at the time of conversion. This structure is often referred to as a "death spiral" financing due to its potential to rapidly dilute existing shareholders if the stock price declines.
  • The issuance of 25,000 commitment shares as additional consideration is also a costly component, further increasing the effective cost of capital compared to a straightforward debt instrument.
  • The "Most Favored Nation" clause and the right to demand repayment from future capital raises are strong investor protections, more common in distressed or high-risk financings than in standard corporate debt or equity offerings.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy UpdateCompany to purchase director and officer insurance for 18 months with two years of tail coverage within 60 calendar days of the closing.2025-10-25Enhances protection for officers and directors, potentially aiding in retention and risk management, but represents an additional cost.
Shareholder RightsCompany acknowledges the potentially dilutive effect of conversion shares and commitment shares on existing shareholders.2025-08-26Highlights a significant risk to existing shareholder value due to the terms of the convertible note.
Shareholder RightsCompany grants piggy-back registration rights to the investor for conversion shares and commitment shares.2025-08-26Facilitates the investor's ability to resell shares, potentially increasing liquidity for the investor but also increasing the supply of shares in the market.

Stakeholder Impact

  • Shareholders: Significant potential for dilution due to the issuance of 25,000 commitment shares and the highly dilutive conversion terms (90% of the lowest closing price over 10 trading days). The "Most Favored Nation" clause could also disadvantage future equity investors.
  • Creditors: New debt obligation of $275,000 with a 10% interest rate and monthly amortization payments, increasing the company's leverage and debt servicing requirements.
  • Management/Employees: The capital infusion provides working capital, which can support ongoing operations and job security in the short term. D&O insurance provides protection for officers and directors.
  • Company Operations: The $200,000 net proceeds are designated for general corporate and working capital, which should support day-to-day operations and business development.

Next Steps

  • Company to use approximately $200,000 net proceeds for general corporate and working capital purposes.
  • Monthly amortization payments on the note are scheduled to begin on February 26, 2026.
  • The note matures on August 26, 2026, at which point all remaining amounts are due.
  • Company to purchase director and officer insurance for 18 months with two years of tail coverage within 60 calendar days of the closing.
  • Company to maintain listing and trading of its Common Stock on the Principal Market.
  • Company to comply with 1934 Act reporting requirements.
  • Company to reserve sufficient shares of common stock for future conversions.
  • Company to provide piggy-back registration rights for the investor's shares.
  • Company to notify the investor of any future financings with more favorable terms (Most Favored Nation clause).

Key Dates

DateDescription
2025-08-26Date of earliest event reported; Securities Purchase Agreement and Promissory Note Issue Date.
2025-09-02Date Form 8-K was signed by Gregory T. Delory, CEO.
2026-02-26First monthly amortization payment due date.
2026-03-26Second monthly amortization payment due date.
2026-04-26Third monthly amortization payment due date.
2026-05-26Fourth monthly amortization payment due date.
2026-06-26Fifth monthly amortization payment due date.
2026-07-27Sixth monthly amortization payment due date.
2026-08-26Maturity Date of the Promissory Note; all remaining outstanding amounts due.

Recommendation

strong sell

The terms of this financing are highly unfavorable and indicative of a company in a precarious financial position. The significant original issue discount, high interest rate, and particularly the extremely dilutive conversion terms (90% of the lowest closing price over 10 trading days) are detrimental to existing shareholders. The substantial penalties upon default and the 'Most Favored Nation' clause further limit the company's future flexibility and increase risk. While the capital raise provides short-term liquidity, the long-term implications for shareholder value are severely negative, suggesting a 'strong sell' recommendation for current holders and avoidance for new investors.

Keywords

Helio Corporation, SEC Filing, Form 8-K, Promissory Note, Convertible Debt, Private Placement, Accredited Investor, Capital Raise, Working Capital, Dilution, Original Issue Discount, Corporate Finance, SEC Reporting, Network 1 Financial Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.